These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3240659)

  • 1. Use of tamoxifen in stage I breast cancer.
    Munar MY; Scholtz JM
    Clin Pharm; 1988 Sep; 7(9):640, 643. PubMed ID: 3240659
    [No Abstract]   [Full Text] [Related]  

  • 2. The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer.
    Williams MR; Gilson D; Marsh L; Morgan DA; Nicholson RI; Elston CW; Griffiths K; Blamey RW
    Eur J Surg Oncol; 1988 Jun; 14(3):235-40. PubMed ID: 3371476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced breast cancer successfully treated with combined tamoxifen and epitiostanol].
    Konishi Y; Morimoto T; Komaki K; Yamakawa T; Mituyama N; Tanaka T; Oomine Y; Monden Y
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2163-7. PubMed ID: 3395140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
    Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
    Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen in breast cancer.
    Drug Ther Bull; 1986 Aug; 24(17):65-7. PubMed ID: 3757793
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy of metastasizing breast cancer with tamoxifen].
    Köhler A; Noss W; Dobberstein N; Stoltmann R; Pohl J
    Z Gesamte Inn Med; 1986 Jan; 41(1):6-9. PubMed ID: 3953121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
    Mouridsen HT; Palshof T; Engelsman E; Sylvester R
    Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone therapy in advanced breast cancer: high dose medroxyprogesterone acetate (MAP) vs tamoxifen (TMX). Preliminary results.
    Pannuti F; Martoni A; Fruet F; Strocchi E; Di Marco AR
    Eur J Cancer (1965); 1980; Suppl 1():93-8. PubMed ID: 6459237
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
    Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
    Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen in premalignant and pre-invasive breast cancer.
    Neven P
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():147-51. PubMed ID: 8298445
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Lee JH; Recht A
    J Clin Oncol; 2003 Jun; 21(12):2260-7. PubMed ID: 12805324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tamoxifen trial - a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer.
    Stewart HJ; Forrest AP; Gunn JM; Hamilton T; Langlands AO; McFadyen IJ; Roberts MM
    Eur J Cancer (1965); 1980; Suppl 1():83-8. PubMed ID: 7032945
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to tamoxifen and fluoxymesterone in a group of breast cancer patients with disease recurrence after cessation of adjuvant tamoxifen.
    Fornander T; Rutqvist LE; Glas U
    Cancer Treat Rep; 1987; 71(7-8):685-8. PubMed ID: 3300966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 20. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.